Skip to main content
. 2024 Nov 7;15:1444686. doi: 10.3389/fimmu.2024.1444686

Table 3.

Severity of adverse reactions reported within 30 days after vaccine (SS).

Adverse Events Zagreb group
(N=599)
Essen group
(N=600)
P value
n (%) n (%)
Injection site (local) 231 38.56 206 34.33 0.134
 Pain 222 37.06 190 31.67 0.052
 Itching 9 1.50 17 2.83 0.164
 Swelling 10 1.67 15 2.50 0.419
 Erythema 8 1.34 13 2.17 0.379
 Induration 4 0.67 4 0.67 1.000
 Rash 1 0.17 0 0.00 0.500
 Other 4 0.67 11 1.83 0.116
Non-injection site (systemic) 128 21.37 121 20.17 0.619
 Weakness 60 10.02 50 8.33 0.319
 Fever 40 6.68 41 6.83 1.000
 Dizziness 36 6.01 33 5.50 0.712
 Headache 30 5.01 25 4.17 0.494
 Diarrhea 20 3.34 11 1.83 0.105
 Abdominal pain 16 2.67 9 1.50 0.164
 Vomiting 3 0.50 8 1.33 0.224
 Myalgia (muscle pain) 12 2.00 10 1.67 0.675
 Arthralgia (joint pain) 10 1.67 4 0.67 0.116
 Hypersensitivity reaction 2 0.33 3 0.50 1.000
 Other 4 0.67 4 0.67 1.000